The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Plasma trough imatinib levels and molecular response in patients of chronic myeloid leukemia (CML): A single institution study from India.
Hemant Malhotra
No relevant relationships to disclose
Pratibha Sharma
No relevant relationships to disclose
Shipra Bhargava
No relevant relationships to disclose
Om Singh Rathode
No relevant relationships to disclose
Bharti Malhotra
No relevant relationships to disclose
Vikram Gota
No relevant relationships to disclose